Ullmann Wealth Partners Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$215K Buy
+3,453
New +$218K 0.02% 170
2017
Q3
– Sell
-999
Closed -$55K – 56
2017
Q2
$55K Hold
999
– – 0.04% 87
2017
Q1
$54K Buy
+999
New +$54.8K 0.04% 80

Other funds holding BMY

Ullmann Wealth Partners Group's BMY Position: Q3 2026 in Review

Ullmann Wealth Partners Group opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,453 shares worth $215K. The stake represents 0.02% of the portfolio and ranks #170 among its holdings. This is a return to the name: Ullmann Wealth Partners Group previously reported a position in BMY as recently as Q2 2017.

Ullmann Wealth Partners Group first reported a position in BMY in Q1 2017 and has held it in 3 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Ullmann Wealth Partners Group held 3,453 shares of Bristol-Myers Squibb worth $215K as of Q3 2026.
  • Bristol-Myers Squibb was a new Ullmann Wealth Partners Group position in Q3 2026.
  • Bristol-Myers Squibb made up 0.02% of Ullmann Wealth Partners Group's portfolio in Q3 2026, its #170 holding.
  • Ullmann Wealth Partners Group first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 3 quarters since.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Ullmann Wealth Partners Group's 13F filing for Q3 2026, filed 2 Nov 2026.